PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 85 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $316,066 | -67.7% | 351,834 | -62.6% | 0.00% | -71.4% |
Q4 2022 | $979,461 | -19.8% | 941,834 | -11.3% | 0.01% | -22.2% |
Q3 2022 | $1,221,000 | -38.5% | 1,061,834 | 0.0% | 0.01% | -43.8% |
Q2 2022 | $1,986,000 | -38.3% | 1,061,834 | 0.0% | 0.02% | -27.3% |
Q1 2022 | $3,217,000 | -19.9% | 1,061,834 | 0.0% | 0.02% | -15.4% |
Q4 2021 | $4,014,000 | -26.9% | 1,061,834 | 0.0% | 0.03% | -29.7% |
Q3 2021 | $5,489,000 | +35.0% | 1,061,834 | 0.0% | 0.04% | +32.1% |
Q2 2021 | $4,067,000 | -25.5% | 1,061,834 | -53.3% | 0.03% | -37.8% |
Q1 2021 | $5,458,000 | -3.9% | 2,272,727 | -0.0% | 0.04% | 0.0% |
Q4 2020 | $5,682,000 | +18.9% | 2,272,731 | -1.5% | 0.04% | 0.0% |
Q3 2020 | $4,777,000 | -34.3% | 2,307,814 | -1.6% | 0.04% | -41.6% |
Q2 2020 | $7,271,000 | +38.1% | 2,345,468 | +57.6% | 0.08% | +32.8% |
Q1 2020 | $5,266,000 | -2.2% | 1,488,175 | +0.0% | 0.06% | 0.0% |
Q4 2019 | $5,387,000 | +139.3% | 1,488,069 | +125.5% | 0.06% | +93.3% |
Q3 2019 | $2,251,000 | – | 660,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynx1 Capital Management LP | 1,136,319 | $3,443,000 | 3.20% |
Aquilo Capital Management, LLC | 3,708,882 | $11,238,000 | 1.65% |
Soleus Capital Management, L.P. | 4,134,868 | $12,529,000 | 1.62% |
GREAT POINT PARTNERS LLC | 2,199,076 | $6,663,000 | 1.61% |
BVF INC/IL | 5,328,239 | $16,145,000 | 0.65% |
Cutter & CO Brokerage, Inc. | 406,229 | $1,231,000 | 0.37% |
WEALTH EFFECTS LLC | 80,400 | $244,000 | 0.11% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $3,116,000 | 0.10% |
Rhenman & Partners Asset Management AB | 300,000 | $909,000 | 0.09% |
Woodline Partners LP | 1,587,475 | $4,810,000 | 0.08% |